NAS10029,813+0.55%S&P7,744+0.28%GOLD$4,071−0.10%BTC$79,851−1.18%VIX16.91−3.48%latest tape · as of 02:01 UTC
The Screen · Industrials · Engineering & Construction
TopBuild Corp
BLD · the NYSE · USD · Market cap $9.9B · 14,707 employees
TopBuild Corp., together with its subsidiaries, engages in the installation and distribution of insulation and other building material products to the construction industry.
FAIL · Does not pass the screen
354.53 USD
Price as of 1 Sep 2026Daily close, not a live quoteLast reviewed 58 days ago
Screened 2026-09-01 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price354.53 USD at the 1 Sep 2026 close
Ethical screenDoes not pass
Last reviewed1 Sep 2026 (58 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 354.53 against the desk's fair-value range, base estimate 341.20, over the last year.
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price354.53 USD
Fair value341.20
Ethical score70.0/100
Our investment reviews on this name
2026-07-02Read Markdown411.08-13.8% to today ✓First review on file: Markdown with results news in the headlines
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
TopBuild Corp holds its Markdown at $354.53. Consolidating, no directional conviction, held for 12 days.
As held on the ledger · 2026-09-01
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 12 days
Price at the screen
$354.53
Valuation
19.92 trailing · 17.04 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.83
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
47.71%
Below 33%
Interest-bearing debt is 47.7% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
16.34%
Below 49%
Money owed to the company is 16.3% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
TopBuild's business is in a permissible area, but its interest-bearing debt is about 48% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BLD's ethical verdict changes
Today BLD does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-09-01 screen. The gold marker is the market price at the same screen. The price runs 3.8% above the base estimate.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-01 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Insulation Supplier Trades Past Fair Value
Picture a builder fitting insulation into a new house on the edge of town. TopBuild sits behind many of those jobs, moving materials through installation crews and a distribution network. Revenue is rising 17 percent a year, return on equity reaches 22 percent, margins sit at 9 percent and the ethical screen is clear, yet the shares sit at 354 dollars against a fair value of 341.
We pass for the simple reason that investors get no margin of safety. The forward multiple of 17 times earnings prices in steady housing demand on a business with only a narrow moat, and the opportunity rating stays at none.
Housing spend moves with interest rates and economic swings, and a narrow competitive edge leaves room for rivals to take share when volumes drop. At this price the numbers do not cover that exposure.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BLD trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Markdown$354.53+0.0%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (9 analysts) rates it buy, with a mean price target of $471.
2026-10-14Markdown$354.53+0.0%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (9 analysts) rates it buy, with a mean price target of $471.
2026-10-02Markdown$354.53+0.0%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (9 analysts) rates it buy, with a mean price target of $471.
2026-08-23Markdown$354.53+0.0%Entry 5
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (9 analysts) rates it buy, with a mean price target of $471.
2026-07-23Markdown$354.53-13.8%Entry 4
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 13.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (9 analysts) rates it buy, with a mean price target of $471.
2026-07-18Markdown$411.08+0.0%Entry 3
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (9 analysts) rates it buy, with a mean price target of $471.
2026-07-03Markdown$411.08+0.0%Entry 2
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markdown$411.08Entry 1
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
